Close Menu

NEW YORK – Roche announced today its cobas Babesia blood test for individual blood donation testing has received marketing approval from the US Food and Drug Administration.

The qualitative in vitro nucleic acid screening test, which can directly detect four common species of Babesia, is Roche's first commercially available whole-blood test to screen donations.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.